PHARMACIE DU GROS FAYT
0823.336.493 · rovalta.com · 27/09/2026
ACTIVE
PHARMACIE DU GROS FAYT
Financial year 2025 · Closed on 31/12/2025
Net result69,5 k €-12,0 %over 1 year
Gross margin340,8 k €-12,6 %over 1 year
Equity773 k €+9,9 %over 1 year
Workforce2,0 ETP+5,3 %over 1 year
Overview
Identity
Source · BCE/KBOPHARMACIE DU GROS FAYT is a Private limited company incorporated in 2010. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Courcelles. It employs on average 2,0 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0823.336.493
- Incorporation
- 23/02/2010
- Legal form
- Private limited company
- Registered office
- Rue de Hubes(CO) 12
6180 Courcelles · WallonieSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 2,0 ETP
Activities (NACE)
Joint committees (1)
- 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Financials
Source · NBB, 17 filingsTrend over 16 financial years
| 2025 | 2024 | 2023 | 2022 | 2022 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 340,8 k € | -12.6% | 390 k € | +17.8% | 331,2 k € | +24.7% | 265,6 k € | -24.9% | 353,5 k € |
| EBITDA | 187,5 k € | -29.0% | 264,3 k € | +29.1% | 204,7 k € | +14.9% | 178,2 k € | -25.3% | 238,5 k € |
| Operating result | 122,2 k € | -34.0% | 185,1 k € | +45.7% | 127 k € | +4.0% | 122,2 k € | -25.8% | 164,7 k € |
| Net result | 69,5 k € | -12.0% | 79 k € | +16.2% | 68 k € | +1.0% | 67,3 k € | -31.5% | 98,2 k € |
| Balance sheet | |||||||||
| Equity | 773 k € | +9.9% | 703,5 k € | +12.6% | 624,5 k € | +12.2% | 556,5 k € | +13.8% | 489,2 k € |
| Total assets | 1,2 M € | -1.3% | 1,3 M € | +6.4% | 1,2 M € | -1.3% | 1,2 M € | -1.0% | 1,2 M € |
| Cash | 136,6 k € | -9.8% | 151,5 k € | +74.3% | 86,9 k € | +11.8% | 77,8 k € | -12.9% | 89,3 k € |
| Debts | 476,4 k € | -15.2% | 562 k € | -0.4% | 564,2 k € | -12.9% | 647,6 k € | -10.8% | 726,2 k € |
| Other | |||||||||
| Workforce | 2,0 ETP | +5.3% | 1,9 ETP | 0.0% | 1,9 ETP | 0.0% | 1,9 ETP | 0.0% | 1,9 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20252 active · 5 ended
Active mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director | since 30/06/2022 | 000 | |
MARTINE DE MOL | Director | 000 |
Ended mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
BASTIEN REGNIER | Mandate | 00 | |
BASTIEN REGNIER | Associate | 00 | |
MARTINE DE MOL | Mandate | 000 | |
MARTINE DE MOL | Manager | 000 |
Other companies at this address
Rue de Hubes(CO) 12 6180 Courcelles| Company | CBE no. |
|---|---|
BMR GESTION● Active | 0635.621.204 |
DE MOL - REGNIER PHARMA● Active | 0897.726.486 |
REGNIER BASTIEN● Active | 0841.757.981 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/04/2022 | 01/04/2021 | 01/04/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/03/2022 | 31/03/2021 |
| Length of the financial year | 12 months | 12 months | 12 months | 9 months | 12 months | 12 months |
| Filing date | 25/08/2026 | 29/08/2025 | 28/08/2024 | 30/08/2023 | 16/09/2022 | 18/10/2021 |
| General meeting | 07/08/2026 | 28/08/2025 | 14/08/2024 | 25/08/2023 | 05/09/2022 | 11/10/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 17 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 07/08/2026 | 25/08/2026 | French | |
| Abridged model | 31/12/2024 | 28/08/2025 | 29/08/2025 | French | |
| Abridged model | 31/12/2023 | 14/08/2024 | 28/08/2024 | French | |
| Abridged model | 31/12/2022 | 25/08/2023 | 30/08/2023 | French | |
| Abridged model | 31/03/2022 | 05/09/2022 | 16/09/2022 | French | |
| Abridged model | 31/03/2021 | 11/10/2021 | 18/10/2021 | French | |
| Abridged modelCorrection | 31/03/2020 | 11/09/2020 | 13/11/2020 | French | |
| Abridged model | 31/03/2020 | 11/09/2020 | 25/10/2020 | French | |
| Abridged model | 31/03/2019 | 08/10/2019 | 23/12/2019 | French | |
| Abridged model | 31/03/2018 | 19/06/2018 | 01/10/2018 | French | |
| Abridged model | 31/03/2017 | 12/10/2017 | 13/11/2017 | French | |
| Abridged model | 31/03/2016 | 10/10/2016 | 23/12/2016 | French | |
| Abridged model | 31/03/2015 | 29/10/2015 | 30/11/2015 | French | |
| Abridged model | 31/03/2014 | 03/10/2014 | 14/10/2014 | French | |
| Abridged model | 31/03/2013 | 22/10/2013 | 25/10/2013 | French | |
| Abridged model | 31/03/2012 | 25/10/2012 | 30/10/2012 | French | |
| Abridged model | 31/03/2011 | 30/11/2011 | 30/11/2011 | French |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active · 5 ended
Active mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director | since 30/06/2022 | 000 | |
MARTINE DE MOL | Director | 000 |
Ended mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
BASTIEN REGNIER | Mandate | 00 | |
BASTIEN REGNIER | Associate | 00 | |
MARTINE DE MOL | Mandate | 000 | |
MARTINE DE MOL | Manager | 000 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates04/07/2022STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - SIEGE SOCIAL - OBJET - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE - ANNEE COMPTABLE
- Restructuring21/06/2011CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring15/10/2010RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...) - DIVERS
- Restructuring08/09/2010RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...) - DIVERS
- Other05/03/2010RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202569,5 k €↓
- 2024Annual accounts 202479 k €↑
- 2023Annual accounts 202368 k €↑
- 2022Annual accounts 202267,3 k €↓
- 2022Annual accounts 202298,2 k €↑
- 2021Annual accounts 202147,3 k €↑
- 2020Annual accounts 20202,1 k €↓
- 2019Annual accounts 201959,3 k €↑
- 2018Annual accounts 201852,3 k €↑
- 2017Annual accounts 201728,4 k €↓
- 2016Annual accounts 201632,9 k €↓
- 2015Annual accounts 201544,9 k €↑
- 2014Annual accounts 201429 k €↑
- 2013Annual accounts 20133,4 k €↓
- 2012Annual accounts 201222 k €↓
- 2011Annual accounts 201160,8 k €
- 23/02/2010IncorporationPrivate limited company